GlassScriptPhysician profile
Allison M Green
NPI 1780172098
$1,513.66
in general payments reported to CMS, 2019-2025
19 companies · $608 in 2025
The $608 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $61.82 · 2023: $354 · 2024: $490 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,381.85 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $337.25 | 2022-2025 | Nexplanon |
| Shield Therapeutics INC | $257.63 | 2024-2025 | |
| Exeltis, USA INC. | $202.71 | 2022-2025 | Slynd |
| Astellas Pharma US INC | $125.67 | 2024-2025 | Veozah |
| Pfizer INC. | $114.34 | 2023-2025 | |
| Abbvie INC. | $76.26 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $61.42 | 2025 | |
| Sage Therapeutics, LLC | $53.91 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $46.79 | 2023-2024 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Sumitomo Pharma America, INC. | $37.80 | 2023 | Myfembree |
| Novo Nordisk INC | $34.44 | 2024-2025 | Wegovy |
| Millicent US INC | $31.84 | 2025 | Intrarosa, Femring, Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $31.67 | 2023 | |
| Myovant Sciences INC. | $20.66 | 2022 | |
| Meditrina | $18.36 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $16.91 | 2025 | Qelbree |
| Integra Lifesciences Corporation | $16.24 | 2023 | Medihoney, Biofix, Biodoptix |
| Dexcom, INC. | $15.63 | 2025 | Dexcom G6 Transmitter |
| Coopersurgical, INC. | $14.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.